01-11-2001 | Original Article
Purified hybrid cells from dendritic cell and tumor cell fusions are superior activators of antitumor immunity
Published in: Cancer Immunology, Immunotherapy | Issue 9/2001
Login to get access01-11-2001 | Original Article
Published in: Cancer Immunology, Immunotherapy | Issue 9/2001
Login to get access